Tag: Viaskin
DBV rises, FDA clears Viaskin Peanut clinical trial to resume
Published on 23/12/2022 at 10:32 Photo credit © Reuters PARIS (Reuters) –…
DBV announces good results for Viaskin Peanut in 1 to 3 year olds
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? Sale ? What course objective? Our experts engage and…
DBV Technologies tumbles on the stock market, another setback for the Viaskin Peanut patch
The title of biotech DBV Technologies fell on the stock market, its decision to withdraw the application for marketing authorization for Viaskin Peanut constituting yet another setback. DBV Technologies tumbles…
DBV Technologies fall, setback for Viaskin Peanut in Europe
DBV Technologies fall, setback for Viaskin Peanut in Europe | Photo credits: DBV Technologies PARIS, December 21 (Reuters) – DBV Technologies unscrews Tuesday on the Paris Stock Exchange after asking…
DBV Technologies takes stock of regulatory developments for Viaskin ™ Peanut – 12/20/2021 at 10:15 PM
Montrouge, France, December 20 (10:15 p.m. CET) 2021 DBV Technologies takes stock of regulatory changes in Viaski n ™ Peanut DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq…